Research
Hormonal
Autophagy is a double-edged sword in muscle health: it is essential for removing damaged components and preventing degeneration, but its hyperactivation contributes to muscle loss in pathological conditions.
Autophagy is your muscle's recycling system. It is essential for removing damaged parts and maintaining health. However, in states of severe stress or disease, this system can become overactive and break down muscle faster than it can be replaced. Balancing this system is key to maintaining muscle mass.
GoodQualifiesHIGH confidence
Hyperactivation of autophagy has been found to contribute to muscle loss in a plethora of conditions... Because autophagy is constantly active in the cell to generate metabolites that sustain cellular core metabolism... an autophagy impairment induces muscle degeneration and weakness.
Why this rating
Strong evidence from knockout mice and pharmacological studies.
Source
Mechanisms of muscle atrophy and hypertrophy: implications in health and disease
Roberta Sartori et al. · Nature Communications · 2021
DOI 10.1038/s41467-020-20123-1
narrative_reviewCited 902×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Muscle hypertrophy is driven by the PI3K-AKT-mTOR pathway, where IGF-1 and insulin signaling promote protein synthesis and inhibit degradation, while myostatin/activin signaling via Smad2/3 inhibits growth.Strong
- Muscle atrophy in catabolic conditions (cancer, diabetes, inactivity) is driven by the upregulation of 'atrogines' like MuRF1 and Atrogin-1, which target structural proteins for degradation via the ubiquitin-proteasome system.Strong
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →